These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37259605)

  • 1. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
    Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
    Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
    Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
    Ohigashi M; Osugi K; Kusunoki Y; Washio K; Matsutani S; Tsunoda T; Matsuo T; Konishi K; Katsuno T; Namba M; Koyama H
    J Diabetes Investig; 2021 Jun; 12(6):940-949. PubMed ID: 33058513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time in range correlates glycated albumin measured immediately after 2 weeks of continuous glucose monitoring.
    Sakai T; Aoyama K; Inazumi K; Kikuchi R; Sato Y; Tada A; Hirata T; Morimoto J
    J Diabetes Complications; 2021 Aug; 35(8):107962. PubMed ID: 34059411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.
    Sonoda S; Okada Y; Torimoto K; Sugai K; Uemura F; Tanaka K; Hajime M; Mori H; Tanaka Y
    J UOEH; 2020; 42(4):299-306. PubMed ID: 33268606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
    Desouza CV; Rosenstock J; Zhou R; Holcomb RG; Fonseca VA
    Endocr Pract; 2015 Nov; 21(11):1195-203. PubMed ID: 26214108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Among Glycemic Biomarkers in Korean Adults: Hemoglobin A1c, Fructosamine, and Glycated Albumin.
    Choi R; Park MJ; Lee S; Lee SG; Lee EH
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin and continuous glucose monitoring metrics across pregnancy in women with pre-gestational diabetes.
    Toft JH; Dalen I; Skadberg Ø; Gøransson LG; Økland I; Bleskestad IH
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e376. PubMed ID: 36121204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between glycated albumin, fructosamine, and HbA1c with neonatal outcomes in a prospective cohort of women with gestational diabetes mellitus.
    Mendes N; Alves M; Andrade R; Ribeiro RT; Papoila AL; Serrano F
    Int J Gynaecol Obstet; 2019 Sep; 146(3):326-332. PubMed ID: 31242319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetes.
    Lee JE; Lee JW; Fujii T; Fujii N; Choi JW
    Biomed Res Int; 2014; 2014():370790. PubMed ID: 25013775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
    Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.